wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38180458-06442107-9B4E-4AC9-951D-ACB523EF77A3
Q38180458-06442107-9B4E-4AC9-951D-ACB523EF77A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38180458-06442107-9B4E-4AC9-951D-ACB523EF77A3
Dolutegravir: an exciting new kid on the block.
P2860
Q38180458-06442107-9B4E-4AC9-951D-ACB523EF77A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38180458-06442107-9B4E-4AC9-951D-ACB523EF77A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e61bf4b0aa30505e8651ad8edd67db10922e6607
P2860
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study.